cbdMDYCBD
YCBD logo
Fair Value
US$2
Share price20 Dec
US$0.5870.8% undervalued intrinsic discount
Loading
1Y-38.06%
7D4.84%

Hemp-Derived CBD And Functional Beverages Will Drive Long-Term Market Share Gains

Analyst Consensus Target compiles analysts opinions to create narratives on stocks using the Analysts Consensus Price Target, forecasted revenue and earnings figures, as well as the transcripts of earnings calls.

Published
20 Dec 25
Views
19
Not Invested

Fair Value vs Share Price

US$2
vs US$0.5870.8% undervalued intrinsic discount
PastFuture-59m44m2018202020222024202520262028Revenue US$39.0mEarnings US$8.1m
27.1%
Revenue growth
20.9%
Profit margin

Recent News & Updates

No updates

Recent updates

No updates

Stay ahead on cbdMD

  • Fair value estimate changes
  • Narrative and analyst updates
  • Key company announcements

Company analysis

Adequate balance sheet with slight risk.

Market capUS$5.9m
PB0.7x
Estimated Growth9.3%
Dividend YieldN/A
Full analysis

CEO & management

T. Kennedy
CEO
5.8yrs
CEO Tenure

Produces and distributes various cannabidiol (CBD) products in the United States and internationally.